Articles & Issues
- Language
- English
- Conflict of Interest
- In relation to this article, we declare that there is no conflict of interest.
- Publication history
-
Received January 24, 2026
Accepted April 25, 2026
Available online August 25, 2026
-
This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/bync/3.0) which permits
unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
All issues
Indirect Electrochemical Sensing of the L-abrine Biomarker of Abrin Toxin Via Enzymatic Oxidation of N-methyl-L-tryptophan
https://doi.org/10.1007/s11814-026-00732-0
Abstract
The biotoxin abrin, if inhaled or ingested, can be fatal to humans within several days. Because of the initial flu-like
symptoms and the lack of analytical technologies for determining abrin poisoning, the high possibility of misdiagnosis
makes this biochemical weapon particularly threatening. This urged us to develop a sensing device for real time monitoring
of abrin poisoning. We introduce an enzyme-linked electrochemical sensor for the detection of the chemical marker
of abrin poisoning, known as N-methyl-L-tryptophan (MT) or more commonly referred to as L-abrine. Indium tin oxide
(ITO) was employed as the electrode substrate for immobilization of the enzyme methyl tryptophan oxidase (MTOX),
which is selective for the MT substrate. The MTOX-immobilized ITO electrode obtained via the amino-glutaraldehyde
cross-linking chemistry exhibited a sensitivity of 23.3 ± 1.28 µA per decade concentration of MT in a linear detection
range from 98.1 pM to 1.17 µM (pH 7 in phosphate-buffered saline), and the detection limit was 22.7 pM. Each of the
electrode modification steps were verified by electrochemical impedance spectroscopy, cyclic voltammetry, and Fourier
transform-infrared spectroscopy. The approximate amount of MTOX immobilized on a 1 cm2
ITO substrate was determined
by cyclic voltammetry in a phosphate buffered saline solution at neutral conditions, revealing 3.3 ± 0.46 µC which
is equivalent to 11.4 pmole of MTOX. With this MT detection strategy in hand, we look to further optimize our approach
toward a rapid clinical diagnostic tool.

